Duloxetine Capsule, Delayed Release
Product Images NDC 70518-1139

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 70518-1139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine 20mg 70518 1139 00

Duloxetine 20mg 70518 1139 00
This is a description of a medication called DULoxetine. It is in the form of a delayed-release capsule containing 20 mg, with a quantity of 30. The capsule is RX-only, and has an NDC number of 70518-1139-00 with a LOT number, and a source NDC of 27241-0097-06. The medication has been manufactured by Ajanta Pharma Ltd, Paithan, India 431 148. It is advised to keep this and all medication out of the reach of children, and the directions for use can be found in the package insert. It should be stored between 20-25°C (88-77°F), with excursions permitted o 15-30°C (59-86°F) [See USP]. The medication has been repackaged by RemedyRepack Ine., Indiana, PA 15701, 724.465.8762.*
FDA Label Image

Duloxetine Fig1

FDA Label Image

Duloxetine Fig10

FDA Label Image

Duloxetine Fig2

Duloxetine Fig2
This is a graph displaying the proportion of patients with relapse over time from randomization to relapse (in days). The graph compares the effects of a placebo and a medication called Duloxetine. The proportion of patients with relapse is on the y-axis, while the time in days from randomization to relapse is shown on the x-axis. The graph indicates that Duloxetine is a more effective treatment compared to the placebo, as fewer patients relapsed while taking it.*
FDA Label Image

Duloxetine Fig3

Duloxetine Fig3
The text is displaying the results of a study that compares the effectiveness of duloxetine in different dosages and placebo on reducing pain in patients. It shows the percentage of patients who experienced a reduction in pain compared to their baseline. However, without the actual percentages, it's difficult to determine the efficacy of the treatment.*
FDA Label Image

Duloxetine Fig4

FDA Label Image

Duloxetine Fig5

FDA Label Image

Duloxetine Fig6

FDA Label Image

Duloxetine Fig8

Duloxetine Fig8
The text appears to be a medical prescription, mentioning a drug named Duloxetine with doses of 60 or 120 mg to be taken once daily. It also shows some numerical values, but their context is unclear, making it difficult to provide more information. Therefore, the description will be: "Prescription instructions for taking Duloxetine drug with doses of 60 or 120 mg once daily. Not available context for the rest of the text."*
FDA Label Image

Duloxetine Fig9

Duloxetine Fig9
The text describes a comparison between a placebo and a medication called duloxetine. Duloxetine is taken once daily at a dosage of 60 mg. The rest of the text appears to be a graph or chart showing the percent improvement in pain from baseline for different time points, ranging from 0 to 100. There are some illegible characters, but the overall meaning is clear.*
FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.